eccogene glp 1 GLP-1 obesity drugs cleared of suicide warning The Multi-Sector Impacts of GLP-1RA

This remains the gold standard for pharmacological weight management despite cost and side effect considerations

The Search for Solutions to Diabetic Kidney Disease Diabetic kidney disease is a pressing concern, often leading to end-stage renal disease (ESRD) and significantly elevating the risk of cardiovascular events

For most researchers focused on weight management, the priority order is: adherence first, side effect management second, appetite alignment third

Denmarks Novo Nordisk had already won the race to get an oral GLP-1 drug onto the market (with a version of Wegovy in December): but Eli Lillys drug could shake up the market

Henkel, I

Whether you can access GLP-1s through this model depends entirely on whether your state chooses to participate